Franklin India Technology Fund-Growth vs TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Franklin India Technology Fund-Growth appears stronger based on its higher star rating of 5 compared to TATA India Pharma & Health Care Fund's rating of 2, indicating better overall performance and management quality. However, while Franklin India Technology Fund has a slightly higher expense ratio of 1.16% versus 1.1% for TATA India Pharma & Health Care Fund, it has underperformed in terms of returns, showing negative 1-year returns and lower CAGR figures over 3 and 5 years. Investors should consider the tradeoff between the higher rating and historical underperformance of Franklin India Technology Fund versus the better recent returns of TATA India Pharma & Health Care Fund.
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option
Tata Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Franklin India Technol... | TATA India Pharma & He... |
|---|---|---|
| NAV | ₹544.36 | ₹38.7 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.16% | 1.1% |
| AUM | ₹1,742 Cr | ₹1,511 Cr |
| 1M Return | +5.45% | +2.72% |
| 3M Return | -0.29% | -3.21% |
| 6M Return | +13.03% | +7.44% |
| 1Y Return | -5.8% | +6.66% |
| 3Y CAGR | +10.29% | +19.59% |
| 5Y CAGR | +7.22% | +15.19% |
| Risk Level | — | — |
| Fund Manager | Anand Radhakrishnan, Srikesh Nair, Varun Sharma | Rupesh Patel, Sonam Udasi |